← back to database
Global healthcare and life-sciences investor backing differentiated, high-growth businesses across medical technology, pharmaceuticals, diagnostics, digital health, health IT, life-science tools, contract research, and contract manufacturing.
Stage focus
Lead / follow
Check size
Ownership target
Specialization
Generalist / Specialist
Specialist
Latest fund size
>$1B AUM
Investing team
Eric BednarskiManaging Partner
Kyle DempseyPartner
Thomas CasdagliPartner
Notable investments
Sangamo Therapeutics, Cara Therapeutics, HLS Therapeutics, SkyCell, Vital Connect, ezono, Ossio, Neurent Medical, GT Medical Technologies